Establishing the role of the FES tyrosine kinase in the pathogenesis, pathophysiology, and severity of sepsis and its outcomes

Abstract

IntroductionSepsis is a result of initial over-activation of the immune system in response to an infection or trauma that results in reduced blood flow and life-threatening end-organ damage, followed by suppression of the immune system that prevents proper clearance of the infection or trauma. Because of this, therapies that not only limit the activation of the immune system early on, but also improve blood flow to crucial organs and reactivate the immune system in late-stage sepsis, may be effective treatments. The tyrosine kinase FES may fulfill this role. FES is present in immune cells and serves to limit immune system activation. We hypothesize that by enhancing FES in early sepsis and inhibiting its effects in late sepsis, the severity and outcome of septic illness can be improved.Methods and analysisIn vitro and in vivo modeling will be performed to determine the degree of inflammatory signaling, cytokine production, and neutrophil extracellular trap (NET) formation that occurs in wild-type (WT) and FES knockout (FES-/-) mice. Clinically available treatments known to enhance or inhibit FES expression (lorlatinib and decitabine, respectively), will be used to explore the impact of early vs. late FES modulation on outcomes in WT mice. Bioinformatic analysis will be performed to examine FES expression levels in RNA transcriptomic data from sepsis patient cohorts, and correlate FES expression data with clinical outcomes (diagnosis of sepsis, illness severity, hospital length-of-stay).Ethics and disseminationEthics approval pending from the Queen’s University Health Sciences & Affiliated Teaching Hospitals Research Ethics Board. Results will be disseminated through scientific publications and through lay summaries to patients and families.

scRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma

“…54 FES, a tyrosine kinase, is involved in various aspects of immune system function, including limiting immune system activation, regulating hematopoietic cell growth, survival, differentiation, and activating macrophages and mast cells. [55][56][57] PRSS21 encodes testosterone, which is anchored to the cell surface through glycosylphosphatidylinositol (GPI), inducing angiogenesis and regulating microvascular endothelial permeability. 58 IFI6, also known as interferon alpha-inducible protein 6, prevents virus-induced ER membrane invasion, impairs viral entry by inhibiting EGFR activation, modulates innate immune responses, and inhibits virus replication.…”

Genetic Insights into the Therapeutic Targets for Essential Hypertension: Mendelian Randomization and Colocalization Analysis

“…The FES proto-oncogene product represents a new participant in regulating angiogenesis, with previous studies indicating its central role in movement, proliferation, differentiation, and survival of cells and in ammation (17)(18)(19). FES is also associated with atherosclerosis, cancer, and infections (20)(21)(22). For example, VEGF induces endothelial sprouting in blood vessels, partially activating PI3 kinase through c-Fes and enhancing capillary morphogenesis through an unknown signaling pathway (23).…”

Fes-deficient macrophages enhance CD8+T cell priming and tumour control through increased proinflammatory cytokine production and presentation

“…Because of the importance of APCs in initiating and sustaining adaptive anti-cancer immune responses, their inhibition or polarization to an immunosuppressive phenotype makes them a potential target for modulation. While pro-inflammatory cytokine production is one of the most important functions in priming anti-cancer immune responses, uncontrolled release of these cytokines can have detrimental and even fatal consequences, such as septic shock (14), autoimmune disorder (15), or cytokine storm (16). To combat this, the human body has evolved various mechanisms to attenuate immune responses to prevent these negative consequences.…”